Login to Your Account



Financings Roundup


Friday, March 15, 2013
• Hyperion Therapeutics Inc., of South San Francisco, completed its follow-on offering of about 2.8 million shares of common stock. In addition, the underwriters exercised their overallotment option in full and purchased an additional 431,250 shares of common stock.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription